Stockreport

Biomea Fusion Highlights Initial Data from the First Two Type 1 Diabetes Patients Dosed with BMF-219 [Yahoo! Finance]

Biomea Fusion, Inc.  (BMEA) 
PDF The first two type 1 diabetes patients enrolled in COVALENT-112 both demonstrated early signs of clinical activity with improved measures of beta-cell function after in [Read more]